Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes

Giordano, Céline; Druyts, Eric; Garber, Gary; Cooper, Curtis

doi:10.1097/meg.0b013e328326f598

Cited by 21 publications

(17 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, in a quantitative study of health care services access specific to hepatitis C virus treatment, Giordano et al [11] employed secondary data and found no difference between immigrants and non-immigrants. However, rate of access was determined by comparing hepatitis C treatment initiation rates for immigrants versus non-immigrants.…”

Section: Discussionmentioning

confidence: 99%

“…Of these, six studies analyzed secondary data and four analyzed primary data. Most studies that analyzed secondary data sought to determine whether or not immigrants and nonimmigrants experienced different rates of access to health care [11][12][13][14]. With the exception of access to cervical cancer screening [15], secondary data analyses revealed no difference in health care access between immigrants and non-immigrants.…”

Section: Trends In Quantitative and Qualitative Studiesmentioning

confidence: 99%

See 1 more Smart Citation

A Scoping Review of Immigrant Experience of Health Care Access Barriers in Canada

Kalich

Heinemann

Ghahari

2015

J Immigrant Minority Health

149

116

View full text Add to dashboard Cite

Canadian population-based surveys report comparable access to health care services between immigrant and non-immigrant populations, yet other research reports immigrant-specific access barriers. A scoping review was conducted to explore research regarding Canadian immigrants' unique experiences in accessing health care, and was guided by the research question: "What is currently known about the barriers that adult immigrants face when accessing Canadian health care services?" The findings of this study suggest that there are unmet health care access needs specific to immigrants to Canada. In reviewing research of immigrants' health care experiences, the most common access barriers were found to be language barriers, barriers to information, and cultural differences. These findings, in addition to low cultural competency reported by interviewed health care workers in the reviewed articles, indicate inequities in access to Canadian health care services for immigrant populations. Suggestions for future research and programming are discussed.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Trends In Quantitative and Qualitative Studiesmentioning

confidence: 99%

A Scoping Review of Immigrant Experience of Health Care Access Barriers in Canada

Kalich

Heinemann

Ghahari

2015

J Immigrant Minority Health

149

116

View full text Add to dashboard Cite

show abstract

“…Pre- and post-HCV test counselling has been identified as an area requiring skills development [42,105], and there is a need for physicians to be responsive to patients’ reports of adverse treatment effects [72]. An obstacle to communication that has received little attention to date is language barriers between some immigrants and minority ethnic groups and their HCV treatment providers [61,106]. …”

Section: Social Level Factorsmentioning

confidence: 99%

Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors

2013

View full text Add to dashboard Cite

BackgroundEvidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains suboptimal. This review seeks to map social factors mediating HCV treatment access.MethodWe undertook a review of the social science and public health literature pertaining to HCV treatment for PWID, with a focus on barriers to treatment access, uptake and completion. Medline and Scopus databases were searched, supplemented by manual and grey literature searches. A two step search was taken, with the first step pertaining to literature on HCV treatment for PWID and the second focusing on social structural factors. In total, 596 references were screened, with 165 articles and reports selected to inform the review.ResultsClinical and individual level barriers to HCV treatment among PWID are well evidenced. These include patient and provider concerns regarding co-morbidities, adherence, and side effect management. Social factors affecting treatment access are less well evidenced. In attempting to map these, key barriers fall into the following domains: social stigma, housing, criminalisation, health care systems, and gender. Key facilitating factors to treatment access include: combination intervention approaches encompassing social as well as biomedical interventions, low threshold access to opiate substitution therapy, and integrated delivery of multidisciplinary care.ConclusionCombination intervention approaches need to encompass social interventions in relation to housing, stigma reduction and systemic changes in policy and health care delivery. Future research needs to better delineate social factors affecting treatment access.

show abstract

“…One Italian study showed that immigrants were significantly less likely than Italian-born patients to receive HBV antiviral therapy [76]. However, other studies have shown no difference in treatment uptake rates among immigrants [79]. Lack of insurance coverage [34] and lack of access to specialist physicians [78] were felt to be barriers to treatment in some studies.…”

Section: Improving Case Identification and Treatment Among Migrantsmentioning

confidence: 99%

Immigration and viral hepatitis

Sharma

Carballo

Feld

et al. 2015

Journal of Hepatology

136

103

View full text Add to dashboard Cite

WHO estimates reveal that the global prevalence of viral hepatitis may be as high as 500 million, with an annual mortality rate of up to 1.3 million individuals. The majority of this global burden of disease is borne by nations of the developing world with high rates of vertical and iatrogenic transmission of HBV and HCV, as well as poor access to healthcare. In 2013, 3.2% of the global population (231 million individuals) migrated into a new host nation. Migrants predominantly originate from the developing countries of the south, into the developed economies of North America and Western Europe. This mass migration of individuals from areas of high-prevalence of viral hepatitis poses a unique challenge to the healthcare systems of the host nations. Due to a lack of universal standards for screening, vaccination and treatment of viral hepatitis, the burden of chronic liver disease and hepatocellular carcinoma continues to increase among migrant populations globally. Efforts to increase case identification and treatment among migrants have largely been limited to small outreach programs in urban centers, such that the majority of migrants with viral hepatitis continue to remain unaware of their infection. This review summarizes the data on prevalence of viral hepatitis and burden of chronic liver disease among migrants, current standards for screening and treatment of immigrants and refugees, and efforts to improve the identification and treatment of viral hepatitis among migrants.

show abstract

Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes

Abstract: In the context of a multidisciplinary, multilingual universal health care system, by studying the influence of barriers to HCV investigation and successful therapy can be abrogated.

Cited by 21 publications

References 25 publications

A Scoping Review of Immigrant Experience of Health Care Access Barriers in Canada

A Scoping Review of Immigrant Experience of Health Care Access Barriers in Canada

Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors

Immigration and viral hepatitis

Contact Info

Product

Resources

About